DK116287D0 - Fremgangsmaade og middel til foroegelse af vaeksten af mamma parenchym - Google Patents

Fremgangsmaade og middel til foroegelse af vaeksten af mamma parenchym

Info

Publication number
DK116287D0
DK116287D0 DK116287A DK116287A DK116287D0 DK 116287 D0 DK116287 D0 DK 116287D0 DK 116287 A DK116287 A DK 116287A DK 116287 A DK116287 A DK 116287A DK 116287 D0 DK116287 D0 DK 116287D0
Authority
DK
Denmark
Prior art keywords
growth
mammal
parenchym
mama
procedure
Prior art date
Application number
DK116287A
Other languages
English (en)
Other versions
DK116287A (da
Inventor
Robert Joseph Collier
Michael Francis Mcgrath
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of DK116287D0 publication Critical patent/DK116287D0/da
Publication of DK116287A publication Critical patent/DK116287A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1808Epidermal growth factor [EGF] urogastrone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/27Growth hormone [GH], i.e. somatotropin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/30Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Dairy Products (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Prostheses (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Liquid Deposition Of Substances Of Which Semiconductor Devices Are Composed (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Seasonings (AREA)
  • Mushroom Cultivation (AREA)
DK116287A 1986-03-07 1987-03-06 Fremgangsmaade og middel til foroegelse af vaeksten af mamma parenchym DK116287A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83747786A 1986-03-07 1986-03-07

Publications (2)

Publication Number Publication Date
DK116287D0 true DK116287D0 (da) 1987-03-06
DK116287A DK116287A (da) 1987-09-08

Family

ID=25274560

Family Applications (1)

Application Number Title Priority Date Filing Date
DK116287A DK116287A (da) 1986-03-07 1987-03-06 Fremgangsmaade og middel til foroegelse af vaeksten af mamma parenchym

Country Status (22)

Country Link
US (1) US5059586A (da)
EP (1) EP0237514B1 (da)
JP (1) JPS62221635A (da)
KR (1) KR900000545B1 (da)
CN (1) CN87102601A (da)
AT (1) ATE93730T1 (da)
AU (1) AU595295B2 (da)
BG (1) BG50926A3 (da)
CA (1) CA1299103C (da)
CS (1) CS272772B2 (da)
DD (1) DD258943A5 (da)
DE (1) DE3787185T2 (da)
DK (1) DK116287A (da)
ES (1) ES2000437T3 (da)
HU (1) HU205007B (da)
IL (1) IL81809A (da)
MX (1) MX170911B (da)
NO (1) NO870946L (da)
NZ (1) NZ219530A (da)
PL (1) PL154182B1 (da)
RU (1) RU2033178C1 (da)
ZA (1) ZA871654B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5182302A (en) * 1986-03-07 1993-01-26 Monsanto Company Method for enhancing growth of mammary parenchyma using a prostaglandin
US5130300A (en) * 1986-03-07 1992-07-14 Monsanto Company Method for enhancing growth of mammary parenchyma
US5130299A (en) * 1986-03-07 1992-07-14 Monsanto Company Method for enhancing growth of mammary parenchyma
IE912345A1 (en) * 1990-08-03 1992-02-12 Pharmacia Ab Treatment of human lactation failure
US5336488A (en) * 1991-08-07 1994-08-09 American Cyanamid Company Method of treating or preventing mastitis in animals with involuting mammary glands by administering recombinant cytokines
US6828111B2 (en) 2000-01-13 2004-12-07 Wayne State University Three-dimensional in vitro model of human preneoplastic breast disease
RU2185198C2 (ru) * 2000-05-15 2002-07-20 Российский Университет Дружбы Народов Способ лечения кисты молочной железы
JP2004536589A (ja) * 2001-05-18 2004-12-09 カナダ国 ウシ上皮成長因子の核酸及びタンパク質配列
JP2017046688A (ja) * 2015-08-31 2017-03-09 株式会社みやぎヘルスイノベーション 体重増加抑制用飲料組成物
CN105194642B (zh) * 2015-10-09 2018-04-17 深圳市容大生物技术有限公司 一种疏通乳房微循环养护自体腺胞的组合物及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4011312A (en) * 1975-06-25 1977-03-08 American Home Products Corporation Prolonged release drug form for the treatment of bovine mastitis
EP0085036A1 (en) * 1982-01-18 1983-08-03 Monsanto Company Method for improved bovine milk production
US4521409A (en) * 1983-10-03 1985-06-04 Cornell Research Foundation, Inc. Use of growth hormone to enhance ruminant mammary development

Also Published As

Publication number Publication date
EP0237514A1 (en) 1987-09-16
NO870946L (no) 1987-09-08
ZA871654B (en) 1987-08-28
ES2000437T3 (es) 1994-01-16
CS151887A2 (en) 1990-06-13
BG50926A3 (bg) 1992-12-15
AU595295B2 (en) 1990-03-29
NZ219530A (en) 1992-12-23
MX170911B (es) 1993-09-22
NO870946D0 (no) 1987-03-06
HU205007B (en) 1992-03-30
HUT47031A (en) 1989-01-30
PL154182B1 (en) 1991-07-31
CN87102601A (zh) 1987-12-16
AU6978887A (en) 1987-09-10
ATE93730T1 (de) 1993-09-15
CS272772B2 (en) 1991-02-12
IL81809A (en) 1993-01-31
KR900000545B1 (ko) 1990-01-31
EP0237514B1 (en) 1993-09-01
IL81809A0 (en) 1987-10-20
CA1299103C (en) 1992-04-21
DD258943A5 (de) 1988-08-10
PL264490A1 (en) 1988-02-18
KR880010773A (ko) 1988-10-24
ES2000437A4 (es) 1988-03-01
JPS62221635A (ja) 1987-09-29
DE3787185D1 (de) 1993-10-07
DK116287A (da) 1987-09-08
DE3787185T2 (de) 1994-02-03
US5059586A (en) 1991-10-22
RU2033178C1 (ru) 1995-04-20

Similar Documents

Publication Publication Date Title
DE3888983D1 (de) Projektor mit Flüssigkristallzellen.
NO166518C (no) Stol med vektsavhengig tilbakestillingskraft for rygglenet
FI875533A0 (fi) Insulinpreparat foer non-parenteral dosering.
IT8323559A0 (it) Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare.
IT8709354A0 (it) Siringa per iniezioni,in specie endovenose,realizzata per poteressere usata una sola volta,senza possibilita' di riaspirazione.
NO156835B (no) Sugbar engangsartikkel, spesielt til anvendelse paa omraadet medisin og hygiene.
DK0412486T3 (da) Antistoffer mod TNF-bindingsprotein I og F(ab)-fragmenter
ES2064355T3 (es) Procedimiento para cultivar celulas recombinantes.
DK116287A (da) Fremgangsmaade og middel til foroegelse af vaeksten af mamma parenchym
NO940180L (no) Anvendelse av IGF-I
ATE54824T1 (de) System zur arzneistoffabgabe mit erhoehter bioakzeptanz.
IT1232755B (it) Procedimento per la determinazione del glucosio in un liquido biologico, e miscela reattiva per l' attuazione del procedimento
SE8400723D0 (sv) Farmaceutisk komposition
ATE22655T1 (de) Infusionsloesungen zur herztherapie.
IT7924433A0 (it) Procedimento per fare aumentare la durata di conservazione di una composizione di riferimento di bilirubina del siero e composizione prodotta mediante detto procedimento.
NO860344L (no) Vevskultur og fremstilling i permeable geler.
DE3871385D1 (de) Fluessigkristallzubereitung.
FI810637A7 (fi) Lääkeaineen imeytymistä edistävien apuaineiden käyttö - laktaamiantibiootteja sisältävissä valmisteissa.
DE3888757D1 (de) Optisch aktive Flüssigkristallkomponenten.
Buturin The effect of phenol on hydrobionts).
ATE97802T1 (de) Infusion sauerstoffreicher perfluorierter fluessigkeit im augapfel.
IT210192Z2 (it) Dispositivo per regolare la posizione dello schienale e/o del poggiagambe in una poltrone osimili.
IT1160361B (it) Polipeptidi attivi nel ridurre i livelli del calcio nel sangue
IT211409Z2 (it) Bocchetta per infissi,con invito conico per assicurare l'inserimento del chiavistello e per determinare il forzamento in chiusura.
IT8619634V0 (it) Apparecchio decodificatore audio da impiantare a contatto diretto sottocutaneo con le diramazione del nervo acustico.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment